Download FREE Report Sample
Download Free sampleEnoxaparin Sodium Injection Market contains market size and forecasts of Enoxaparin Sodium Injection in global, including the following market information:
Global Enoxaparin Sodium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Enoxaparin Sodium Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Enoxaparin Sodium Injection companies in 2021 (%)
The global Enoxaparin Sodium Injection market was valued at 3132.6 million in 2021 and is projected to reach US$ 5292.8 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
20 mg/0.2mL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Enoxaparin Sodium Injection include Sanofi, Fresenius Kabi, Rovi, Amphastar, Teva, Nanjing King-friend, Techdow (Hepalink), Sandoz and Apotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Enoxaparin Sodium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enoxaparin Sodium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Enoxaparin Sodium Injection Market Segment Percentages, by Type, 2021 (%)
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Global Enoxaparin Sodium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Enoxaparin Sodium Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Enoxaparin Sodium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Enoxaparin Sodium Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enoxaparin Sodium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Enoxaparin Sodium Injection revenues share in global market, 2021 (%)
Key companies Enoxaparin Sodium Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Enoxaparin Sodium Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Fresenius Kabi
Rovi
Amphastar
Teva
Nanjing King-friend
Techdow (Hepalink)
Sandoz
Apotex
Cipla
Taj Pharma
Hangzhou Jiuyuan Gene Engineering
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Suzhou Erye Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy